fitness clinics: a gold scale, a measuring tape and a tagged dumbbell on a mat in an empty night gym

AUTOPSY: The Business of Fitness Clinics. Are They Genuine, or Is Body Shaming the Product?

Fitness clinics are posting record membership numbers and a growing pile of regulator letters at the same time. Gyms, boutique studios and weight-loss wings all sit under that label now. The live autopsy is blunt: are fitness clinics a genuine health business, or is body shaming the product that keeps the card on file?

The short cut is both, and the books actually support that split. The floor can be real sweat, real visits and, in the approved-drug lane, real trial data. The sales layer has a long habit of poking the insecurity, then making the exit harder than the entrance.

The Body: What Fitness Clinics Actually Sell

Start with the cash, not the mantra. IBISWorld estimates the US gym, health and fitness club operations market at $47.1 billion in 2026, up 1.8 percent on the year. That is an industry-revenue estimate for the gym core of fitness clinics, not a stock price. The Health & Fitness Association, formerly IHRSA, measures something different: a $22.4 billion US economic impact across more than 55,300 club and studio locations, from a 7 May 2024 analysis by John Dunham and Associates, a figure the 2026 HFA Global Report still cites. Two rulers, two answers.

Demand is not a rumour. HFA says US membership hit a 2025 record: an estimated 81 million Americans (the count covers ages six and older), up 5.2 percent from 2024, a 26.1 percent penetration rate. Including non-members, more than 100 million people used a facility. Fourth quarter 2025 was the 19th straight quarter of visit growth, and inactive memberships fell to a record-low 4.6 percent. Life Time’s revenue rose 14.3 percent to nearly $3 billion. HFA’s Benchmarking Report, published 30 September 2025, put 2024 median revenue growth at 9.9 percent, net membership growth at 5.5 percent, and retention at 66.4 percent. A December 2025 HFA survey estimated consumers intended to put about $60 billion toward health and fitness goals in 2026, an intention figure, not cash already spent.

The clinic wing is smaller. Grand View Research estimated the US medical weight loss clinics market at $1.17 billion in 2024 and $1.21 billion in 2025, with a projected 4.42 percent compound annual growth rate from 2025 to 2030. Those are research-house estimates, not audited filings. GLP-1 drugs moved from diabetes cabinets into the front window, and a lot of fitness clinics added a prescription desk beside the squat rack.

This is still a body business. Global Celebrity Meter Media priced the commercial side of a silhouette in The Physique Premium. EuroCelebs has the taste-and-culture file in Why Some Men Are Attracted to Curves. Motivations Masters has the men’s-gym cousin in our look at whether looksmaxxing is about health or being desired. The desire is not a secret. The question is what fitness clinics are selling when they point at the mirror.

The Shame Layer: The Ads That Got Banned, and the One That Didn’t

The most famous body-shame ad of the last decade is a plot twist. Protein World’s “Are you beach body ready?” London Underground poster drew 378 complaints. On 1 July 2015 the UK Advertising Standards Authority did not uphold the offence or social-responsibility challenges. It said the line was unlikely to cause serious or widespread offence, and would not shame women with different body shapes into taking a slimming supplement. The same ruling still barred the ad from running again in that form, because of separate health and weight-loss claim issues. In 2016 the Mayor of London announced a Transport for London crackdown on ads likely to pressure people toward unrealistic body images.

Later ads did not all get the same pass. In a 2016 ruling, a Diet Chef commercial was found socially irresponsible after the ASA said it dwelt on a woman’s distress and implied that happiness and confidence arrived only through weight loss. On a paid Facebook ad seen on 30 July 2025, weight-loss clinic Chequp used the line “I don’t want to be skinny. I just don’t want to be the biggest person in the room.” The ASA upheld a social-responsibility complaint, saying the ad exploited body-image insecurities, and also told the firm not to promote prescription-only medicines to the public. Some fitness clinics sell a result. Some sell the fear of being the biggest person in the room, then sell the result.

The Lock: Memberships, Cancellations and Click-to-Cancel

Inside fitness clinics, joining is usually one screen. Leaving is where the model shows its teeth. On 20 August 2025 the Federal Trade Commission sued Fitness International, LLC and Fitness & Sports Clubs, LLC, the operators behind LA Fitness, alleging cancellation was far harder than enrolment: an in-person form taken to an operations manager during limited hours, or a mailed notice, with no simple online path for a long stretch, and “hundreds of millions of dollars” in unwanted recurring fees. Those are allegations in a live case, not a final finding. The chain has argued it recommends rather than requires certified mail and later added an online cancellation flow. As of November 2026 the suit is still pending.

The federal “click-to-cancel” rule is not the referee. The FTC finalized a national negative-option rule in October 2024. The Eighth Circuit vacated it in July 2025, shortly before it was due to take effect, on procedural grounds. In March 2026 the FTC asked whether to update its older Negative Option Rule, with comments due 13 April 2026. There is no nationwide click-to-cancel rule in force. CNBC reported that a New York City subscription rule took effect on 1 October 2026, and that more than half of US states already have automatic-renewal laws. Easy in, sticky out remains a battleground for fitness clinics.

The New Wing: GLP-1 Desks Inside Fitness Clinics

Approved GLP-1 medicines have trial receipts. In the STEP 1 study, published in the New England Journal of Medicine in 2021, adults on once-weekly 2.4 mg semaglutide plus a lifestyle program lost 14.9 percent of body weight at 68 weeks, versus 2.4 percent on placebo plus the same lifestyle program. That is an average on an FDA-approved drug in a controlled trial, not a coupon for a compounded vial.

The clinic boom ran ahead of that distinction. Compounded drugs are not FDA-approved, the agency keeps repeating, and they are not generics. On 3 March 2026 the FDA issued 30 warning letters to telehealth companies for false or misleading claims about compounded GLP-1 products, including language that implied sameness with approved drugs. As of 31 May 2026 it had received 990 adverse-event reports associated with compounded semaglutide and more than 730 with compounded tirzepatide. Some reports involved dosing errors, and some patients were hospitalized. The agency says causation is not always provable, and underreporting is likely. On 14 July 2025 the FTC announced a proposed settlement with Southern Health Solutions, doing business as NextMed, over alleged deceptive weight-loss marketing around GLP-1 access, including hidden costs, an unsubstantiated 53-pound average-loss claim, and stalled cancellations. The order, finalized in September 2025, required $150,000 in consumer redress. Fitness clinics that added a shot desk inherited the gym’s cancellation habits and the drug market’s advertising risks at the same time.

What the Evidence Says Actually Works

Strip out the before-and-after lighting and the ledger is calmer. The US Preventive Services Task Force recommends intensive behavioral programs, diet, activity, monitoring and support, for adults with obesity, and its reviews have found modest average extra weight loss versus usual care. Exercise alone is a weaker weight-loss tool than diet and exercise together. Approved GLP-1 therapy plus lifestyle change produced much larger average losses in STEP 1 than lifestyle change alone. HFA research argues that pairing those medicines with structured exercise can help protect lean mass, an association finding, not a regulator’s verdict. Trial averages are not a personal prescription. This is a business autopsy of fitness clinics, not a treatment plan. The honest read is not that fitness clinics are fake. People are turning up. Visits rose for 19 straight quarters. Retention was 66.4 percent in that 2024 benchmarking sample, so a large share still walks.

The Autopsy Ledger of Fitness Clinics

Here is the sourced ledger on fitness clinics.

Exhibit Genuine, sourced Shame or lock-in, sourced
Market IBISWorld estimates US gym and club operations at $47.1 billion in 2026. HFA: estimated 81 million members in 2025, 19 straight quarters of visit growth. Grand View estimates US medical weight loss clinics at $1.21 billion in 2025.
Advertising ASA, 1 July 2015: body-shame complaints against Protein World’s poster were not upheld. TfL tightened body-image ads in 2016. ASA later ruled Diet Chef and a 2025 Chequp ad socially irresponsible.
Memberships HFA: inactive memberships at 4.6 percent in 2025. Life Time revenue up 14.3 percent to nearly $3 billion. FTC suit, 20 August 2025: alleges LA Fitness made cancellation far harder than sign-up. Pending. Federal click-to-cancel rule is not in force.
GLP-1 clinics STEP 1 (NEJM, 2021): 14.9 percent average loss on approved weekly semaglutide plus lifestyle, versus 2.4 percent, at 68 weeks. FDA: 30 telehealth warning letters, 3 March 2026; 990 compounded-semaglutide adverse-event reports as of 31 May 2026. FTC-NextMed redress: $150,000.

The Verdict

Are fitness clinics genuine or body shaming? They are a genuine, growing service industry that still uses shame, and sticky billing, as sales tools. The membership boom and the visit data are documented. Approved medicine, in a trial, moved the scale further than lifestyle coaching alone. Body shaming is also documented, not as a feeling but as ad copy UK regulators have rejected in specific cases, and as cancellation designs the FTC has taken to court as allegations. A club can be both a place where people get stronger and a machine that rents insecurity on a monthly draft. The tell is whether the exit is as clear as the entrance, and whether the pitch is a plan or a panic.

Principals who want that kind of judgment on the record can look at Billionaire Meter’s November 2026 list of the world’s richest people, then bring a standard, not a mood, to AI Polymath Bidding before the 24 November 2026 window. Family offices and executives can request an Executive Feature, from $349 to $499, through the Private Qualification Desk.

FAQ

Are fitness clinics genuine or just body shaming?

Both, on the evidence. Record 2025 gym membership and 19 straight quarters of visit growth, reported by the Health & Fitness Association, show a real service business. UK ASA rulings against specific diet and clinic ads, plus a pending FTC cancellation case, show that shame and lock-in are also part of how some operators sell.

How big is the US gym and weight-loss clinic market?

IBISWorld estimates US gym, health and fitness club operations at $47.1 billion in 2026. The Health & Fitness Association cites a $22.4 billion US economic impact from a 2024 analysis, a different measure. Grand View Research estimated US medical weight loss clinics at $1.21 billion in 2025.

Did the UK ban Protein World’s “beach body ready” ad for body shaming?

Not on that charge. On 1 July 2015 the ASA did not uphold complaints that the poster was offensive or socially irresponsible. It said the ad still could not appear again in that form because of separate health and weight-loss claim issues. Transport for London later tightened body-image advertising rules in 2016.

Is the FTC click-to-cancel rule in force?

No. The FTC finalized a national rule in October 2024, and the Eighth Circuit vacated it in July 2025 before it took effect. In March 2026 the agency asked for comments on a possible new negative-option rule. Enforcement continues under existing law, including the August 2025 LA Fitness suit, which remains pending.

Are compounded semaglutide products FDA-approved?

No. The FDA says compounded drugs are not FDA-approved and are not the same as generics. On 3 March 2026 it issued 30 warning letters to telehealth companies over compounded GLP-1 marketing claims. As of 31 May 2026 it had logged 990 adverse-event reports tied to compounded semaglutide, without always being able to prove the drug caused the event.

Leave a Reply

Your email address will not be published. Required fields are marked *